Reprogramming.
Hematopoiesis.
Immunity.
Lab

We are studying how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired from the fields of stem cell biology, immunology, and cancer we use an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate our findings into novel gene and cell therapies.
Research

Merging Stem Cells with Immunology by Cell Fate Reprogramming. Learn more about our research lines:
Latest Publications
In Vivo Dendritic Cell Reprogramming for Cancer Immunotherapy
Ervin Ascic, Fritiof Åkerström, Malavika Sreekumar Nair, André Rosa, Ilia Kurochkin, Olga Zimmermannova, Xavier Catena, Nadezhda Rotankova, Charlotte Veser, Michal Rudnik, Tommaso Ballocci, Tiffany Schärer, Xiaoli Huang, Maria de Rosa Torres, Emilie Renaud, Marta Velasco Santiago, Özcan Met, David Askmyr, Malin Lindstedt, Lennart Greiff, Laure-Anne Ligeon, Irina Agarkova, Inge Marie Svane, Cristiana F. Pires, Fábio F. Rosa, and Carlos-Filipe Pereira
September 5, 2024
Science
GATA2 Mitotic Bookmarking Is Required for Definitive Haematopoiesis
Rita Silvério-Alves, Ilia Kurochkin, Anna Rydström, Camila Vazquez Echegaray, Jakob Haider, Matthew Nicholls, Christina Rode, Louise Thelaus, Aida Yifter Lindgren, Alexandra Gabriela Ferreira, Rafael Brandão, Jonas Larsson, Marella de Bruijn, Javier Martin-Gonzalez, Carlos-Filipe Pereira
August 14, 2023 / 14:4645
Nature Communications
Team

We are a diverse group – molecular biologists, MDs, PharmDs, tumor immunologists, stem cell biologists and computational scientists – at all career stages. We architect strategies to dissect and manipulate immune cell identity.
Looking for an opportunity? Join our international team!
Funders
Latest News
Filipe Pereira awarded the Emerging Alumni Leader Award 2025 from Imperial College London

Filipe Pereira completed his PhD in Biomedical Sciences in 2009 at Imperial College London, UK. He is now being awarded the prestigious Emerging Alumni Award for Imperial’s graduates with breakthroughs that placed them as “rising stars, innovators, game-changers and future leaders”. This award celebrates inspiring mentors and great leaders in their respective fields, who are unafraid of taking risks and collaborating to produce significant social impact and tackle global problems.
Luís Oliveira Wins the Researcher’s Grand Prix 2024

Luís Oliveira won the Forskar Grand Prix, securing the fifth win in a row for Lund University. The competition involves researchers from all over Sweden and the prize is awarded to the candidate who best presents their research in an engaging and entertaining way. At the final in Stockholm, Luís impressed an audience of 550 students, several of whom felt truly inspired and are considering a career in science.
Filipe Pereira and team are awarded with the Pfizer Award for Basic Research

The research study “Restoring tumor immunogenicity with dendritic cell reprogramming” was awarded with the Pfizer Award for Basic Research. The findings depicted in the Science Immunology publication in 2023 reported a strategy to overcome tumor evasion mechanisms by the cell fate reprogramming of tumor cells into dendritic cells.